HomepageVEEV • NYSE
add
Veeva Systems
Vorige slotkoers
$Â 281,64
Dag-range
$Â 270,92 - $Â 280,86
Jaar-range
$Â 177,41 - $Â 291,69
Beurswaarde
45,08Â mld. USD
Gem. volume
1,72Â mln.
Koers/winst
58,53
Dividendrendement
-
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | apr 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 759,04Â mln. | 16,71% |
Bedrijfskosten | 351,49Â mln. | 11,13% |
Netto inkomsten | 228,19Â mln. | 41,15% |
Netto winstmarge | 30,06 | 20,92% |
Winst per aandeel | 1,97 | 31,33% |
EBITDA | 243,55Â mln. | 44,40% |
Effectief belastingtarief | 23,64% | — |
Balans
Totale activa
Totale passiva
(USD) | apr 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 6,07Â mld. | 27,35% |
Totale activa | 7,77Â mld. | 25,50% |
Totale passiva | 1,55Â mld. | 19,70% |
Totaal aandelenvermogen | 6,21 mld. | — |
Uitstaande aandelen | 163,41 mln. | — |
Koers-boekwaardeverhouding | 7,39 | — |
Rendement op activa | 7,74% | — |
Rendement op kapitaal | 9,58% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | apr 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 228,19Â mln. | 41,15% |
Operationele kasstroom | 877,16Â mln. | 14,88% |
Kasstroom uit beleggingen | -52,11Â mln. | 80,87% |
Kasstroom uit financiering | 20,38Â mln. | 432,39% |
Nettomutatie in liquide middelen | 846,20Â mln. | 71,40% |
Vrije kasstroom | 843,22Â mln. | 14,14% |
Over
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of July 9, 2025, it has a market capitalization of US$46.1 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Opgericht
2007
Hoofdvestiging
Website
Werknemers
7.291